Pfizer Says Vaccine is Safe for Young Children

(New York, NY) -- Pfizer says its COVID vaccine is safe and effective on younger children.  

The results of a trial involving kids ages five to eleven showed the vaccine led to antibody responses that were comparable to those in people ages 16 to 25 who got the shots.  

Those in the younger age group were given a lower dose of the vaccine, but it still included two shots administered three weeks apart. Vaccine side effects were also similar.  

Pfizer Chairman and CEO Albert Bourla said they plan to submit the trial results to the FDA and other regulators "with urgency."